Full Text View
Tabular View
No Study Results Posted
Related Studies
Suramin in Treating Patients With Recurrent Primary Brain Tumors
This study has been completed.
Study NCT00002639   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Neoplasms
Neoplasms by Site
Nervous System Diseases
Interventions listed in this trial
chemotherapy
suramin
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Antinematodal Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Trypanocidal Agents
Sponsors listed in this trial
Emory University
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services